文献速递疼痛医学

伤害性疼痛、神经病理性疼痛与无痛对照者的肠道微生物组特征:病例对照研究

Gut microbiome profiles in patients with nociceptive pain, neuropathic pain, and pain-free controls: a case-control study.
PubMed 文献 · Reg Anesth Pain Med · 2026-06-03

该纵向病例对照研究对伤害性下背痛(n=10)、神经病理性下背痛(n=10)及无痛对照(n=10)在基线和3个月后进行16S rRNA基因(V4)测序。结果显示基于熵的α多样性和整体微生物群落结构在各组间及时间上无差异,仅低丰度类群有细微变化,提示肠道微生物组用于慢性疼痛分层的局限性。

要点

  • 基于熵的α多样性指数在各组间及时间上无差异。
  • 整体微生物群落结构在疼痛组与对照间无差异。
  • 肠道微生物组差异细微,以低丰度类群变化为主。

核心结论

  • 慢性疼痛表型间的肠道微生物组差异细微,主要表现为低丰度类群变化而非广泛群落改变。
  • 微生物组用于慢性疼痛分层存在局限性,需更大规模整合性研究。

研究设计与样本

  • 纵向病例对照研究,纳入伤害性下背痛(n=10)、神经病理性下背痛(n=10)和无痛对照(n=10)。
  • 在基线和3个月后采集粪便,采用16S rRNA基因(V4)测序分析肠道微生物组。
  • 疼痛患者按标准治疗后再采样,对照者再采样以捕捉背景时间变化。

主要发现

  • 基于熵的α多样性指数在各组间及时间上无差异。
  • 基于丰富度的指标在稀疏化后配对比较中提示神经病理性为主组可能降低,但整体组效应未达常规统计显著性。
  • 整体微生物群落结构在疼痛组与对照间无差异,在属或扩增子序列变异水平未检测到群体特异性或群体与时间交互效应。

临床怎么用

  • 不建议基于当前16S rRNA基因测序的肠道微生物组特征对慢性下背痛进行伤害性与神经病理性分层。
  • 慢性疼痛的微生物组评估应关注低丰度类群并需更大样本的整合性研究验证。

局限性

  • 样本量小(每组n=10),可能不足以检测细微差异。
  • 仅采用16S rRNA基因(V4)测序,分辨率有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Gut microbiota have been implicated in pain modulation through immune, inflammatory, and neurobiological pathways, yet whether distinct gut microbial signatures differentiate nociceptive from neuropathic low back pain remains unclear. METHODS AND ANALYSIS: In this longitudinal study, we profiled the gut microbiome of individuals with nociceptive low back pain (n=10), neuropathic low back pain (n=10), and pain-free controls (n=10) at baseline and after 3 months. Pain patients were resampled following standard-of-care treatment, while controls were resampled to capture background temporal variation. Gut microbial profiles were characterized using 16S rRNA gene (V4) sequencing. Alpha diversity was analyzed using mixed-effects models, beta diversity using Bray-Curtis, weighted UniFrac, and centered log-ratio-Euclidean distances, and differential abundance using Analysis of Compositions of Microbiomes with Bias Correction 2 (ANCOM-BC2). RESULTS: Entropy-based alpha-diversity indices did not differ between groups or over time. Richness-based metrics suggested a possible reduction in the neuropathic-dominant group in pairwise contrasts after rarefaction, although omnibus group effects did not reach conventional statistical significance. Overall microbial community structure did not differ between pain groups and controls, and no population-specific or population-by-time effects were detected at the genus or amplicon sequence variant level. CONCLUSION: Together, these findings indicate that gut microbiome differences across chronic pain phenotypes are subtle, characterized mainly by changes in low-abundance taxa rather than broad community shifts, underscoring limitations of microbiome-based stratification in chronic pain and the need for larger, integrative studies.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Goudman L, Vandeputte D, Forget P, et al. Gut microbiome profiles in patients with nociceptive pain, neuropathic pain, and pain-free controls: a case-control study. Reg Anesth Pain Med. 2026. PMID: 42236126. doi:10.1136/rapm-2026-107796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。